This Is MS Multiple Sclerosis Knowledge & Support Community

Welcome to This is MS, the leading forum for Multiple Sclerosis research and support. Join our friendly community of patients, caregivers, and researchers celebrating over 20 years of delivering hope through knowledge.
https://www.thisisms.com/forum/

Phase I trial data for remyelinating antibody in MS released

https://www.thisisms.com/forum/viewtopic.php?t=25896

Page 1 of 1

Phase I trial data for remyelinating antibody in MS released

Posted: Mon Feb 02, 2015 7:59 am
by MSUK
Acorda Therapeutics has today announced safety and tolerability data from a Phase 1 clinical trial of rHIgM22, a remyelinating antibody being studied for the treatment of multiple sclerosis. The trial, which followed participants for up to six months after receiving a single dose of rHIgM22, found no dose-limiting toxicities at any of the five dose levels studied. Based on this, the Company intends to advance clinical development of rHIgM22..... Read More - http://www.ms-uk.org/emergingtherapies

Re: Phase I trial data for remyelinating antibody in MS rele

Posted: Fri Mar 20, 2015 4:43 pm
by carolsue
Science magazine has an informative article about so-called natural antibodies, including rHIgM22. Fascinating. And reminds me that we understand so so little about the immune system! http://www.sciencemag.org/content/347/6226/1058.full
All times are UTC-08:00
Page 1 of 1

Powered by phpBB® Forum Software © phpBB Limited